[1] Fujii-Kuriyama Y，Kawajiri K. Molecular mechanisms of the physiological functions of the aryl hydrocarbon (dioxin) receptor，a multifunctional regulator that senses and responds to environmental stimuli[J]. Pro Jpn Acad Ser B Phys Biol Sci，2010，86(1)：40-53.

[2] Androutsopoulos VP，Tsatsakis AM，Spandidos DA. Cytochrome P450 CYP1A1：wider roles in cancer progression and prevention [J]. BMC Cancer，2009，9：187.

[3] National Toxicology P. NTP technical report on the toxicology and carcinogenesis studies of 2，2'，4，4'，5，5'-hexachlorobiphenyl (PCB 153) (CAS No. 35065-27-1) in female Harlan Sprague-Dawley rats (Gavage studies)[J]. Natl Toxicol Program Tech Rep Ser，2006，529：4-168.

[4] National Toxicology P. NTP technical report on the toxicology and carcinogenesis studies of 2，3，7，8-tetrachlorodibenzo-p-dioxin (TCDD) (CAS No. 1746-01-6) in female Harlan Sprague-Dawley rats (Gavage Studies)[J]. Natl Toxicol Program Tech Rep Ser，2006，521：4-232.

[5] Shimizu Y，Nakatsuru Y，Ichinose M，et al. Benzo[a]pyrene carcinogenicity is lost in mice lacking the aryl hydrocarbon receptor[J]. Proc Natl Acad Sci USA，2000，97(2)：779-782.

[6] Matsumoto Y，Ide F，Kishi R，et al. Aryl hydrocarbon receptor plays a significant role in mediating airborne particulate- induced carcinogenesis in mice[J]. Environ Sci Technol， 2007，41(10)：3775-3780.

[7] Puga A，Ma C，Marlowe JL. The aryl hydrocarbon receptor cross-talks with multiple signal transduction pathways[J]. Biochem Pharmacol，2009，77(4)：713-722.

[8] Dietrich C，Kaina B. The aryl hydrocarbon receptor (AhR) in the regulation of cell-cell contact and tumor growth[J]. Carcinogenesis，2010，31(8)：1319-1328.

[9] Yang X，Liu D，Murray TJ，et al. The aryl hydrocarbon receptor constitutively represses c-myc transcription in human mammary tumor cells[J]. Oncogene，2005，24(53)：7869-7881.

[10] Korzeniewski N，Wheeler S，Chatterjee P，et al. A novel role of the aryl hydrocarbon receptor (AhR) in centrosome amplification-implications for chemoprevention[J]. Mol Cancer， 2010，9：153.

[11] Wang CK，Chang H，Chen PH，et al. Aryl hydrocarbon receptor activation and overexpression upregulated fibroblast growth factor-9 in human lung adenocarcinomas[J]. Int J Cancer，2009，125(4)：807-815.

[12] Peng TL，Chen J，Mao W，et al. Potential therapeutic significance of increased expression of aryl hydrocarbon receptor in human gastric cancer[J]. World J Gastroenterol，2009， 15(14)：1719-1729.

[13] Hayashibara T，Yamada Y，Mori N，et al. Possible involvement of aryl hydrocarbon receptor (AhR) in adult T-cell leukemia (ATL) leukemogenesis：constitutive activation of AhR in ATL[J]. Biochem Biophys Res Commun，2003， 300(1)：128-134.

[14] Koliopanos A，Kleeff J，Xiao Y，et al. Increased arylhydrocarbon receptor expression offers a potential therapeutic target for pancreatic cancer[J]. Oncogene，2002， 21(39)： 6059-6070.

[15] Gluschnaider U，Hidas G，Cojocaru G，et al. beta-TrCP inhibition reduces prostate cancer cell growth via upregulation of the aryl hydrocarbon receptor[J]. PLoS One，2010，5(2)： 9060.

[16] Ishida M，Mikami S，Kikuchi E，et al. Activation of the aryl hydrocarbon receptor pathway enhances cancer cell invasion by upregulating the MMP expression and is associated with poor prognosis in upper urinary tract urothelial cancer[J]. Carcinogenesis，2010，31(2)：287-295.

[17] Dever DP，Opanashuk LA. The aryl hydrocarbon receptor contributes to the proliferation of human medulloblastoma cells [J]. Mol Pharmacol，2012，81(5)：669-678.

[18] Gramatzki D，Pantazis G，Schittenhelm J，et al. Aryl hydrocarbon receptor inhibition downregulates the TGF-beta/ Smad pathway in human glioblastoma cells[J]. Oncogene， 2009，28(28)：2593-2605.

[19] Andersson P，McGuire J，Rubio C，et al. A constitutively active dioxin/aryl hydrocarbon receptor induces stomach tumors [J]. Proc Natl Acad Sci USA，2002，99(15)：9990-9995.

[20] Moennikes O，Loeppen S，Buchmann A，et al. A constitutively active dioxin/aryl hydrocarbon receptor promotes hepatocarcinogenesis in mice[J]. Cancer Res，2004，64(14)： 4707-4710.

[21] Hsu EL，Yoon D，Choi HH，et al. A proposed mechanism for the protective effect of dioxin against breast cancer[J]. Toxicol Sci，2007，98(2)：436-444.

[22] Hall JM，Barhoover MA，Kazmin D，et al. Activation of the aryl-hydrocarbon receptor inhibits invasive and metastatic features of human breast cancer cells and promotes breast cancer cell differentiation[J]. Mol Endocrinol，2010，24(2)： 359-369.

[23] Hirabayashi Y，Inoue T. Aryl hydrocarbon receptor biology and xenobiotic responses in hematopoietic progenitor cells[J]. Biochem Pharmacol，2009，77(4)：521-535.

[24] Inuzuka H，Fukushima H，Shaik S，et al. Novel insights into the molecular mechanisms governing Mdm2 ubiquitination and destruction[J]. Oncotarget，2010，1(7)：685-690.

[25] Su JM，Lin P，Wang CK，et al. Overexpression of cytochrome P450 1B1 in advanced non-small cell lung cancer：a potential therapeutic target[J]. Anticancer Res，2009，29(2)：509-515.

[26] Ambolet-Camoit A，Bui LC，Pierre S，et al. 2，3，7，8-tetrachlorodibenzo-p-dioxin counteracts the p53 response to a genotoxicant by upregulating expression of the metastasis marker agr2 in the hepatocarcinoma cell line HepG2[J]. Toxicol Sci，2010，115(2)：501-512.

[27] Papoutsis AJ，Lamore SD，Wondrak GT，et al. Resveratrol prevents epigenetic silencing of BRCA-1 by the aromatic hydrocarbon receptor in human breast cancer cells[J]. J Nutr，2010，140(9)：1607-1614.

[28] Jeffy BD，Chirnomas RB，Romagnolo DF. Epigenetics of breast cancer：polycyclic aromatic hydrocarbons as risk factors [J]. Environ Mol Mutagen，2002，39(2/3)：235-244.

[29] Hanahan D，Weinberg RA. Hallmarks of cancer：the next generation[J]. Cell，2011，144(5)：646-674.

[30] Singh KP，Garrett RW，Casado FL，et al. Aryl hydrocarbon receptor-null allele mice have hematopoietic stem/progenitor cells with abnormal characteristics and functions[J]. Stem Cells Dev，2011，20(5)：769-784.

[31] Gasiewicz TA，Singh KP，Casado FL. The aryl hydrocarbon receptor has an important role in the regulation of hematopoiesis：implications for benzene-induced hematopoietic toxicity[J]. Chem Biol Interact，2010，184(1/2)：246-251.

[32] Barhoover MA，Hall JM，Greenlee WF，et al. Aryl hydrocarbon receptor regulates cell cycle progression in human breast cancer cells via a functional interaction with cyclin-dependent kinase 4 [J]. Mol Pharmacol，2010， 77(2)：195-201.

[33] Abdelrahim M，Smith R，Safe S. Aryl hydrocarbon receptor gene silencing with small inhibitory RNA differentially modulates Ah-responsiveness in MCF-7 and HepG2 cancer cells[J]. Mol Pharmacol，2003，63(6)：1373-1381.

[34] Watabe Y，Nazuka N，Tezuka M，et al. Aryl hydrocarbon receptor functions as a potent coactivator of E2F1-dependent trascription activity[J]. Biol Pharm Bull， 2010，33(3)：389-397.

[35] Park KT，Mitchell KA，Huang G，et al. The aryl hydrocarbon receptor predisposes hepatocytes to Fas-mediated apoptosis[J]. Mol Pharmacol，2005，67(3)：612-622.

[36] Vogel CF，Li W，Wu D，et al. Interaction of aryl hydrocarbon receptor and NF-kappaB subunit RelB in breast cancer is associated with interleukin-8 overexpression[J]. Arch Biochem Biophys，2011，512(1)：78-86.

[37] Singh NP，Nagarkatti M，Nagarkatti PS. Role of dioxin response element and nuclear factor-kappaB motifs in 2，3，7，8-tetrachlorodibenzo-p-dioxin-mediated regulation of Fas and Fas ligand expression[J]. Mol Pharmacol， 2007， 71(1)：145-157.

[38] Broccardo CJ，Billings RE，Andersen ME，et al. Probing the control elements of the CYP1A1 switching module in H4IIE hepatoma cells[J]. Toxicol Sci，2005，88(1)：82-94.

[39] Bock KW，Kohle C. Ah receptor- and TCDD-mediated liver tumor promotion：clonal selection and expansion of cells evading growth arrest and apoptosis[J]. Biochem Pharmacol， 2005，69(10)：1403-1408.

[40] Chiba T，Uchi H，Yasukawa F，et al. Role of the arylhydrocarbon receptor in lung disease[J]. Int Arch Allergy Immunol，2011，155( Sup 1)： 129-134.

[41] Weiss C，Faust D，Schreck I，et al. TCDD deregulates contact inhibition in rat liver oval cells via Ah receptor，JunD and cyclin A[J]. Oncogene，2008，27(15)：2198-2207.

[42] Monk SA，Denison MS，Rice RH. Transient expression of CYP1A1 in rat epithelial cells cultured in suspension[J]. Arch Biochem Biophys，2001，393(1)：154-162.

[43] Ikuta T，Kobayashi Y，Kawajiri K. Cell density regulates intracellular localization of aryl hydrocarbon receptor[J]. J Biol Chem，2004，279(18)：19209-19216.

[44] Ikuta T，Namiki T，Fujii-Kuriyama Y，et al. AhR protein trafficking and function in the skin[J]. Biochem Pharmacol， 2009，77(4)：588-596.

[45] Aragon AC，Kopf PG，Campen MJ，et al. In utero and lactational 2，3，7，8-tetrachlorodibenzo-p-dioxin exposure：effects on fetal and adult cardiac gene expression and adult cardiac and renal morphology[J]. Toxicol Sci，2008， 101(2)：321-330.

[46] Kung T，Murphy KA，White LA. The aryl hydrocarbon receptor (AhR) pathway as a regulatory pathway for cell adhesion and matrix metabolism[J]. Biochem Pharmacol，2009，77(4)： 536-546.

[47] Larsen MC，Brake PB，Pollenz RS，et al. Linked expression of Ah receptor，ARNT，CYP1A1，and CYP1B1 in rat mammary epithelia，in vitro，is each substantially elevated by specific extracellular matrix interactions that precede branching morphogenesis[J]. Toxicol Sci，2004，82(1)：46-61.

[48] Roman AC，Carvajal-Gonzalez JM，Rico-Leo EM，et al. Dioxin receptor deficiency impairs angiogenesis by a mechanism involving VEGF-A depletion in the endothelium and transforming growth factor-beta overexpression in the stroma [J]. J Biol Chem，2009，284(37)：25135-25148.

[49] Mulero-Navarro S，Pozo-Guisado E，Perez-Mancera PA，et al. Immortalized mouse mammary fibroblasts lacking dioxin receptor have impaired tumorigenicity in a subcutaneous mouse xenograft model[J]. J Biol Chem，2005，280(31)：28731-28741.

[50] Zudaire E，Cuesta N，Murty V，et al. The aryl hydrocarbon receptor repressor is a putative tumor suppressor gene in multiple human cancers[J]. J Clin Invest，2008，118(2)：640-650.

[51] Matthews J，Gustafsson JA. Estrogen receptor and aryl hydrocarbon receptor signaling pathways[J]. Nucl Recep Signal，2006，4：e016.

[52] Okino ST，Pookot D，Basak S，et al. Toxic and chemopreventive ligands preferentially activate distinct aryl hydrocarbon receptor pathways：implications for cancer prevention[J]. Cancer Prev Res，2009，2(3)：251-256.

[53] Wihlen B，Ahmed S，Inzunza J，et al. Estrogen receptor subtype- and promoter-specific modulation of aryl hydrocarbon receptor-dependent transcription[J]. Mol Cancer Res，2009， 7(6)：977-986.

[54] Labrecque MP，Takhar MK，Hollingshead BD，et al. Distinct roles for aryl hydrocarbon receptor nuclear translocator and ah receptor in estrogen-mediated signaling in human cancer cell lines[J]. PLoS One，2012，7(1)：29545.

[55] Jensen KA，Luu TC，Chan WK. A truncated Ah receptor blocks the hypoxia and estrogen receptor signaling pathways：a viable approach for breast cancer treatment[J]. Mol Pharm， 2006，3(6)：695-703.

[56] Bidgoli SA，Ahmadi R，Zavarhei MD. Role of hormonal and environmental factors on early incidence of breast cancer in Iran [J]. Sci Total Environ，2010，408(19)：4056-4061.

[57] De Souza VR，Cabrera WK，Galvan A，et al. Aryl hydrocarbon receptor polymorphism modulates DMBA-induced inflammation and carcinogenesis in phenotypically selected mice [J]. Int J Cancer，2009，124(6)：1478-1482.

[58] Karin M. Nuclear factor-kappaB in cancer development and progression[J]. Nature，2006，441(7092)：431-436.

[59] Chen PH，Chang H，Chang JT，et al. Aryl hydrocarbon receptor in association with RelA modulates IL-6 expression in non-smoking lung cancer[J]. Oncogene，2012，31(20)： 2555-2565.

[60] Platten M，Litzenburger U，Wick W. The aryl hydrocarbon receptor in tumor immunity[J]. Oncoimmunology，2012， 1(3)：396-397.

[61] Boverhof DR，Tam E，Harney AS，et al. 2，3，7，8-Tetrachlorodibenzo-p-dioxin induces suppressor of cytokine signaling 2 in murine B cells[J]. Mol Pharmacol， 2004， 66(6)：1662-1670.